Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

Speculation is mounting GlaxoSmithKline's CEO Emma Walmsley may pay the price for the company’s lacklustre performance, after the dreaded activist investor Elliott Management built a stake in ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

GlaxoSmithKline (GSK) appears to be focusing more on finding a new CEO than any large M&A deals after last year's $20 billion asset swap with Novartis, according to a briefing following strong Q1 ...

Consumer healthcare company Haleon Pakistan Limited on Thursday named Qawi Naseer as the next Chief Executive Officer (CEO) ...

Cofounder and CEO Jareeporn Jarukornsakul built industrial parks developer WHA from the ground up. Now she’s facing the ...

Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma ...

A U.S. House committee on Tuesday asked 23andMe's co-founder to testify next month as it launched an investigation into the ...

The Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...